Surface Oncology Inc. (SURF)
NASDAQ: SURF
· Real-Time Price · USD
1.07
-0.01 (-0.93%)
At close: Sep 07, 2023, 10:00 PM
Surface Oncology Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 30M | 30M | 60M | 30.15M | 30.55M | 31.06M | 2.69M | 90.1M | 89.71M | 89.2M |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 30M | 30M | 60M | 30.15M | 30.55M | 31.06M | 2.69M | 90.1M | 89.71M | 89.2M |
Operating Income | -89.39M | -88.37M | -61.87M | -64.06M | -60.65M | -54.62M | -76.01M | 15.33M | 20.46M | 24.51M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -92.51M | -89.53M | -63.59M | -66.3M | -62.96M | -56.73M | -78.48M | 12.91M | 17.03M | 21.21M |
Net Income | -94.01M | -91.62M | -64.67M | -67.23M | -63.55M | -56.73M | -78.48M | 12.91M | 17.03M | 21.21M |
Selling & General & Admin | 26.36M | 24.21M | 24.87M | 26.18M | 26.02M | 26.03M | 25.13M | 26.79M | 25.85M | 24.41M |
Research & Development | 59.79M | 64.16M | 67M | 68.04M | 65.18M | 59.65M | 53.57M | 47.98M | 43.4M | 40.27M |
Other Expenses | n/a | 144K | 189K | 196K | 216K | 95K | 72K | 65K | 45K | 22K |
Operating Expenses | 86.15M | 88.37M | 91.87M | 94.21M | 91.2M | 85.68M | 78.7M | 74.77M | 69.25M | 64.69M |
Interest Expense | 5.02M | 2.64M | 2.39M | 2.92M | 2.51M | 2.19M | 2.54M | 2.48M | 3.48M | 3.33M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 86.15M | 88.37M | 91.87M | 94.21M | 91.2M | 85.68M | 78.7M | 74.77M | 69.25M | 64.69M |
Income Tax Expense | 1.5M | 2.09M | 1.08M | 931K | 589K | n/a | n/a | -410K | -410K | -410K |
Shares Outstanding (Basic) | 60.72M | 60.63M | 60.56M | 59.05M | 54.65M | 48.61M | 46.44M | 45.24M | 43.63M | 41.62M |
Shares Outstanding (Diluted) | 60.72M | 60.63M | 60.56M | 59.05M | 54.65M | 49.82M | 46.44M | 45.24M | 43.63M | 41.62M |
EPS (Basic) | -1.55 | -1.56 | -1.1 | -1.27 | -1.31 | -1.28 | -1.77 | 0.41 | 0.46 | 0.46 |
EPS (Diluted) | -1.55 | -1.56 | -1.1 | -1.27 | -1.31 | -1.28 | -1.77 | 0.31 | 0.36 | 0.36 |
EBITDA | -95.27M | -93.76M | -68.05M | -62.35M | -59.36M | -53.4M | -74.75M | 16.59M | 21.31M | 25.33M |
EBIT | -66.3M | -65.7M | -40.01M | -40.01M | -37.07M | -31.16M | -52.57M | 15.4M | 34.87M | 38.89M |
Depreciation & Amortization | 4.33M | 2.83M | 2M | 2.04M | 1.6M | 1.51M | 1.57M | 1.6M | 1.62M | 1.62M |